(Q43183760)

15 November 2017

The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds (English)

1 reference

15 November 2017

A M Gray

1

1 reference

15 November 2017

P S Spencer

series ordinal

2

1 reference

15 November 2017

R D Sewell

series ordinal

3

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Pharmacology

15 November 2017

1 reference

15 November 2017

124

1 reference

15 November 2017

4

1 reference

15 November 2017

669-674

1 reference

Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

Further studies on opiate receptors that mediate antinoception: tooth pulp stimulation in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

A classification of opiate receptors that mediate antinociception in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

Binding of a labeled antidepressant to rat brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Interaction of tricyclic antidepressants with opiate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Psychogenic facial pain. Part 2: Management and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Pain, depression, and illness behavior in a Pain Clinic population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

On the specificity of naloxone as an opiate antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

The analgesic effect of tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Depression masquerading as diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Differentiation of potent μ- and κ-opiate agonists using heat and pressure antinociceptive profiles and combined potency analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701882

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701882

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

9690858

1 reference